Abstract
Determination of urinary drug concentrations can prove to be very useful in the monitoring of patients who are receiving a variety of synthetic opioids. Through the use of liquid chromatography-tandem mass spectrometry, the simultaneous measurement of synthetic opioids provides for smaller sample volume requirements along with gains in throughput and an increase in the sensitivity of the analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Musshoff F, Trafkowski J, Kuepper U et al (2006) An automated and fully validated LC-MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites. J Mass Spectrom 41:633–640
Patel BN, Sharma N, Sanyal M et al (2009) An accurate, rapid and sensitive determination of tramadol and its active metabolite O-desmethyltramadol in human plasma by LC-MS/MS. J Pharm Biomed Anal 49:354–366
Gergov M, Nokua P, Vuori E et al (2009) Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry. Forensic Sci Int 186:36–43
Kelly T, Doble P, Dawson M (2005) Chiral analysis of methadone and its major metabolites (EDDP and EMDP) by liquid chromatography-mass spectrometry. J Chromatogr B 814:315–323
Sanchez C, Koerner PJ, Countryman S et al (2010) Development of a high-throughput LC/MS/MS assay for 13 commonly prescribed pain management drugs from urine with cleanup using solid phase extraction (SPE). Phenomenex Application TN-1070
Etter ML, George S, Graybiel K et al (2005) Determination of free and protein-bound methadone and its major metabolite EDDP: enantiomeric separation and quantitation by LC/MS/MS. Clin Biochem 38:1095–1102
Shakleya DM, Jansson LM, Huestis MA (2007) Validation of a LC-APCI-MS/MS method for quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3,3-diphenylpyraline (EMDP) in infant plasma following protein precipitation. J Chromatogr B 856:267–272
Coopman V, Cordonnier J, Pien K et al (2007) LC-MS/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple Durogesic® transdermal therapeutic systems. Forensic Sci Int 169:223–227
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Garby, D.M., Cheryk, L.A. (2012). Synthetic Opioid Analysis by LC-MS/MS. In: Langman, L., Snozek, C. (eds) LC-MS in Drug Analysis. Methods in Molecular Biology, vol 902. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-934-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-61779-934-1_6
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-933-4
Online ISBN: 978-1-61779-934-1
eBook Packages: Springer Protocols